Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg. 1967;46(4):489–91.
Article CAS PubMed Google Scholar
Melzack R, Wall PD. Pain mechanisms: a new theory. Science (New York, NY). 1965;150(3699):971–9. https://doi.org/10.1126/science.150.3699.971.
Article CAS PubMed Google Scholar
Sdrulla AD, Guan Y, Raja SN. Spinal cord stimulation: clinical efficacy and potential mechanisms. Pain Practice : The Official Journal of World Institute of Pain. 2018;18(8):1048–67. https://doi.org/10.1111/papr.12692.
Costantini A. Spinal cord stimulation. Minerva Anestesiol. 2005;71(7–8):471–4.
• Blackburn AZ, Chang HH, DiSilvestro K, Veeramani A, McDonald C, Zhang AS, Daniels A. Spinal cord stimulation via percutaneous and open implantation: systematic review and meta-analysis examining complication rates. In World Neurosurgery. (2021);154. https://doi.org/10.1016/j.wneu.2021.07.077. This study utilized 32 articles and compared SCS implantation via a percutaneous and open approach while providing thorough data on a variety of metrics, including complication rates involving equipment, technical, and medical issues.
Hayek SM, Veizi E, Hanes M. Treatment-limiting complications of percutaneous spinal cord stimulator implants: a review of eight years of experience from an academic center database. Neuromodulation J Int Neuromodulation Soc. 2015;18(7):603–8; discussion 608–9. https://doi.org/10.1111/ner.12312.
Shaparin N, Gritsenko K, Agrawal P, Kim S, Wahezi S, Gitkind A, Hascalovici J, Vydyanathan A, Bernstein J, Dizdarevic A, Mehta N, Kaufman A. A retrospective case series of a novel spinal cord stimulator trial technique with less displacement and migration of the trial leads. Pain Res Manage. 2019;2019:1236430. https://doi.org/10.1155/2019/1236430.
Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg. 2004;100(3 Suppl Spine):254–67. https://doi.org/10.3171/spi.2004.100.3.0254.
Mekhail NA, Mathews M, Nageeb F, Guirguis M, Mekhail MN, Cheng J. Retrospective review of 707 cases of spinal cord stimulation: indications and complications. Pain Practice : The Official Journal of World Institute of Pain. 2011;11(2):148–53. https://doi.org/10.1111/j.1533-2500.2010.00407.x.
Motov S, Aftahy K, Jörger A-K, Wagner A, Meyer B, Shiban E. High-frequency spinal cord stimulation in failed back surgery syndrome patients with predominant low back pain-single-center experience. Neurosurg Rev. 2021;44(5):2809–18. https://doi.org/10.1007/s10143-020-01462-5.
Article PubMed PubMed Central Google Scholar
Gupta M, Abd-Elsayed A, Hughes M, Rotte A. A retrospective review of lead migration rate in patients permanently implanted with percutaneous leads and a 10 kHz SCS device. Pain Res Manage. 2021;2021:6639801. https://doi.org/10.1155/2021/6639801.
Gazelka HM, Freeman ED, Hooten WM, Eldrige JS, Hoelzer BC, Mauck WD, Moeschler SM, Pingree MJ, Rho RH, Lamer TJ. Incidence of clinically significant percutaneous spinal cord stimulator lead migration. Neuromodulation J Int Neuromodulation Soc. 2015;18(2):123–5; discussion 125. https://doi.org/10.1111/ner.12184.
Speltz Paiz R, Kaizer A, Jain SV, Darrow DP, Shankar H, Goel V. Lead and pulse generator migration after spinal cord stimulation implantation: insights from an analysis of 7322 patients. Neuromodulation J Int Neuromodulation Soc. 2022. https://doi.org/10.1016/j.neurom.2022.06.001
• Beletsky A, Liu C, Alexander E, Hassanin SW, Vickery K, Loomba M, Winston N, Chen J, Gabriel RA. The association of psychiatric comorbidities with short-term and long-term outcomes following spinal cord stimulator placement. Neuromodulation J Int Neuromodulation Soc. 2023. https://doi.org/10.1016/j.neurom.2022.12.010. In addition to having a large sample size of 12,751 SCS cases, this study was novel in how it separated the cases into those containing psychiatric comorbidities and those with no psychiatric comorbidities and evaluated how this affected postprocedural outcomes following implantation, including complications and reoperation rates.
Jenkinson RH, Wendahl A, Zhang Y, Sindt JE. Migration of epidural leads during spinal cord stimulator trials. J Pain Res. 2022;15:2999–3005. https://doi.org/10.2147/JPR.S378937.
Article CAS PubMed PubMed Central Google Scholar
Babu R, Hazzard MA, Huang KT, Ugiliweneza B, Patil CG, Boakye M, Lad SP. Outcomes of percutaneous and paddle lead implantation for spinal cord stimulation: a comparative analysis of complications, reoperation rates, and health-care costs. Neuromodulation J Int Neuromodulation Soc. 2013;16(5):418–26; discussion 426–7. https://doi.org/10.1111/ner.12065.
Mollica S, Awad M, Teddy PJ. Lead migration in neuromodulation. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 2021;90:32–5. https://doi.org/10.1016/j.jocn.2021.05.014.
Oh BH, Kim HT, Yim KH, Park YS. Percutaneously inserted unilateral lead migration salvaged with a paddle electrode. Pain Practice : The Official Journal of World Institute of Pain. 2020;20(5):544–9. https://doi.org/10.1111/papr.12871.
Lee JJ, Simpson RK, Dalm B. Permanent paddle-lead trial for spinal cord stimulation. Cureus. 2018;10(5):e2645. https://doi.org/10.7759/cureus.2645.
Article PubMed PubMed Central Google Scholar
Leplus A, Voirin J, Cuny E, Onno M, Billot M, Rigoard P, Fontaine D. Is spinal cord stimulation still effective after one or more surgical revisions? Neuromodulation J Int Neuromodulation Soc. 2023. https://doi.org/10.1016/j.neurom.2023.03.009.
Antonovich DD, Gama W, Ritter A, Wolf BJ, Nobles RH, Selassie MA, Hillegass MG. Reoperation rates of percutaneous and paddle leads in spinal cord stimulator systems: a single-center retrospective analysis. Pain Med (Malden, Mass). 2021;22(1):34–40. https://doi.org/10.1093/pm/pnaa215.
Simopoulos T, Aner M, Sharma S, Ghosh P, Gill JS. Explantation of percutaneous spinal cord stimulator devices: a retrospective descriptive analysis of a single-center 15-year experience. Pain Med (Malden, Mass). 2019;20(7):1355–61. https://doi.org/10.1093/pm/pny245.
Simopoulos T, Sharma S, Aner M, Gill JS. The long-term durability of multilumen concentric percutaneous spinal cord stimulator leads. Pain Practice: The Official Journal of World Institute of Pain. 2018;18(7):845–9. https://doi.org/10.1111/papr.12682.
Kim TH, Lee PB, Son HM, Choi JB, Moon JY. Spontaneous lead breakage in implanted spinal cord stimulation systems. Korean J Pain. 2010;23(1):78–81. https://doi.org/10.3344/kjp.2010.23.1.78.
Article PubMed PubMed Central Google Scholar
Heidecke V, Rainov NG, Burkert W. Hardware failures in spinal cord stimulation for failed back surgery syndrome. Neuromodulation J Int Neuromodulation Soc. 2000;3(1):27–30. https://doi.org/10.1046/j.1525-1403.2000.00027.x.
Gill JS, Kohan LR, Hasoon J, Urits I, Viswanath O, Cai VL, Yazdi C, Aner MM, Kaye AD, Simopoulos TT. A survey on the choice of spinal cord stimulation parameters and implantable pulse generators and on reasons for explantation. Orthop Rev. 2022;14(4):39648. https://doi.org/10.52965/001c.39648.
Costandi S, Mekhail N, Azer G, Mehanny DS, Hanna D, Salma Y, Bolash R, Saweris Y. Longevity and utilization cost of rechargeable and non-rechargeable spinal cord stimulation implants: a comparative study. Pain Practice : The Official Journal of World Institute of Pain. 2020;20(8):937–45. https://doi.org/10.1111/papr.12926.
Hajiabadi MM, Vicheva P, Unterberg A, Ahmadi R, Jakobs M. A single-center, open-label trial on convenience and complications of rechargeable implantable pulse generators for spinal cord stimulation: The Recharge Pain Trial. Neurosurg Rev. 2023;46(1):36. https://doi.org/10.1007/s10143-022-01940-y.
Article PubMed PubMed Central Google Scholar
Abejón D, Vancamp T, Monzón EM. A cost-consequence analysis examining the differences between non-rechargeable and rechargeable systems. Anest Pain Med 2020;10(1):e100308. https://doi.org/10.5812/aapm.100308.
Hornberger J, Kumar K, Verhulst E, Clark MA, Hernandez J. Rechargeable spinal cord stimulation versus non-rechargeable system for patients with failed back surgery syndrome: a cost-consequences analysis. Clin J Pain. 2008;24(3):244–52. https://doi.org/10.1097/AJP.0b013e318160216a.
Deer TR, Pope JE, Falowski SM, Pilitsis JG, Hunter CW, Burton AW, Connolly AT, Verrills P. Clinical longevity of 106,462 rechargeable and primary cell spinal cord stimulators: real world study in the medicare population. Neuromodulation J Int Neuromodulation Soc. 2023;26(1):131–8. https://doi.org/10.1016/j.neurom.2022.04.046.
Levy R, Henderson J, Slavin K, Simpson BA, Barolat G, Shipley J, North R. Incidence and avoidance of neurologic complications with paddle type spinal cord stimulation leads. Neuromodulation J Int Neuromodulation Soc. 2011;14(5):412–22; discussion 422. https://doi.org/10.1111/j.1525-1403.2011.00395.x.
Bendersky D, Yampolsky C. Is spinal cord stimulation safe? A review of its complications. World Neurosurg. 2014;82(6):1359–68. https://doi.org/10.1016/j.wneu.2013.06.012.
Hagedorn JM, Deer TR, Falowski SM, Yadav A, Comer A, Al-Asadi Z, Engle AM. An observational study of intraoperative neuromonitoring as a safety mechanism in placement of percutaneous dorsal root ganglion stimulation and spinal cord stimulation systems. J Pain Res. 2020;13:3349–53. https://doi.org/10.2147/JPR.S289416.
Article PubMed PubMed Central Google Scholar
Lawton MT, Porter RW, Heiserman JE, Jacobowitz R, Sonntag VK, Dickman CA. Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome. J Neurosurg. 1995;83(1):1–7. https://doi.org/10.3171/jns.1995.83.1.0001.
Article CAS PubMed Google Scholar
Petraglia FW, Farber SH, Gramer R, Verla T, Wang F, Thomas S, Parente B, Lad SP. The incidence of spinal cord injury in implantation of percutaneous and paddle electrodes for spinal cord stimulation. Neuromodulation J Int Neuromodulation Soc. 2016;19(1):85–90. https://doi.org/10.1111/ner.12370.
Buvanendran A, Young AC. Spinal epidural hematoma after spinal cord stimulator trial lead placement in a patient taking aspirin. Reg Anesth Pain Med. 2014;39(1):70–2. https://doi.org/10.1097/AAP.0000000000000029.
Moeschler SM, Warner NS, Lamer TJ, Bendel MA, Warner MA, Eldrige JS, Mauck WD, Gazelka HM, Kor DJ, Hoelzer BC. Bleeding complications in patients undergoing percutaneous spinal cord stimulator trials and implantations. Pain Med (Malden, Mass). 2016;17(11):2076–81. https://doi.org/10.1093/pm/pnw124.
Scranton RA, Skaribas IM, Simpson RK. Spinal stimulator peri-electrode masses: case report. J Neurosurg Spine. 2015;22(1):70–4. https://doi.org/10.3171/2014.10.SPINE1425.
al Tamimi, M., Aoun, S. G., & Gluf, W. Spinal cord compression secondary to epidural fibrosis associated with percutaneously placed spinal cord stimulation electrodes: case report and review of the literature. World Neurosurg. 2017;104:1051.e1-1051.e5. https://doi.org/10.1016/j.wneu.2017.05.152.
Hwang R, Field N, Kumar V, Paniccioli S, Grey R, Briotte M, Sukul V, Pilitsis JG. Intraoperative neuromonitoring in percutaneous spinal cord stimulator placement. Neuromodulation J Int Neuromodulation Soc. 2019;22(3):341–6. https://doi.org/10.1111/ner.12886.
Esquer Garrigos Z, Farid S, Bendel MA, Sohail MR. Spinal cord stimulator infection: approach to diagnosis, management, and prevention. Clin Infect Dis. 2020;70(12):2727–35.
留言 (0)